Company Name: Progenics Pharmaceuticals Inc.
Progenics Pharmaceuticals Inc. is engaged in the development of oncology medicines. The company’s developmental pipeline includes both diagnostic and therapeutic product candidates for prostate cancer and a treatment for pheochromocytoma and paraganglioma.
Ticker Symbol: PGNX (NASDAQ)
Company Website: www.progenics.com
Headquarters: Tarrytown, NY